A Call to Standardize Teratoma Assays Used to Define Human Pluripotent Cell Lines
- 1 May 2010
- journal article
- editorial
- Published by Elsevier in Cell Stem Cell
- Vol. 6 (5) , 412-414
- https://doi.org/10.1016/j.stem.2010.04.009
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cellsNature Biotechnology, 2009
- Alternative Induced Pluripotent Stem Cell Characterization Criteria for In Vitro ApplicationsCell Stem Cell, 2009
- Broader Implications of Defining Standards for the Pluripotency of iPSCsCell Stem Cell, 2009
- Guidelines and Techniques for the Generation of Induced Pluripotent Stem CellsCell Stem Cell, 2008
- Evolution of microarray analysisNeurobiology of Aging, 2006
- The Road From Teratocarcinoma to Human Embryonic Stem CellsStem Cell Reviews and Reports, 2005
- Minimum information about a microarray experiment (MIAME)—toward standards for microarray dataNature Genetics, 2001
- Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell linesNature, 1984